Holen Sie sich die Stockscreener-App
96.52
4.24%
3.93
Handel nachbörslich:
96.52
Schlusskurs vom Vortag:
$92.59
Offen:
$92.95
24-Stunden-Volumen:
1.81M
Relative Volume:
0.81
Marktkapitalisierung:
$19.10B
Einnahmen:
$7.68B
Nettoeinkommen (Verlust:
$903.80M
KGV:
21.69
EPS:
4.45
Netto-Cashflow:
$1.14B
1W Leistung:
+2.65%
1M Leistung:
+5.81%
6M Leistung:
-12.03%
1J Leistung:
-12.52%
1-Tages-Spanne:
$92.58
$96.79
1-Wochen-Bereich:
$92.58
$96.79
52-Wochen-Spanne:
$89.24
$116.71
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
96.52 | 18.60B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Hochstufung | Roth Capital | Neutral → Buy |
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Is Zimmer Biomet Holdings Inc. a good long term investmentExceptional market positioning - jammulinksnews.com
What drives Zimmer Biomet Holdings Inc. stock priceDynamic profit expansion - jammulinksnews.com
What analysts say about Zimmer Biomet Holdings Inc. stockExceptional stock performance - Autocar Professional
Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA (NYSE:ZBH) - Seeking Alpha
Jim Cramer Expresses Bullishness on Zimmer’s Acquisition of Monogram Technologies - MSN
Zimmer Biomet Holdings Inc. Stock Analysis and ForecastPowerful growth strategies - printweek.in
What You Need To Know Ahead of Zimmer Biomet's Earnings Release - MSN
Needham Maintains a Neutral Stance on Zimmer Biomet Holdings (ZBH) - MSN
ZBH Stock Set to Benefit From New Monogram Technologies Buyout Deal - MSN
Jim Cramer Bullish on Zimmer Biomet's Acquisition of Monogram Technologies - AInvest
Zimmer Expands Robotics Portfolio Acquiring Monogram Technologies for $177 Million - MSN
Zimmer Biomet Holdings Surges to 444th in Market Rankings with $235 Million Trading Volume - AInvest
Zimmer Biomet’s SWOT analysis: stock faces challenges amid strategic acquisitions - Investing.com Australia
Zimmer Biomet Q2 Earnings Preview: Navigating Market ChallengesNews and Statistics - IndexBox
What You Need To Know Ahead Of Zimmer Biomet's Earnings Release - Barchart.com
17 Stocks on Jim Cramer’s Radar - Insider Monkey
Zimmer bets on autonomous surgery with Monogram purchase - Yahoo Finance
Zimmer Biomet wins price target raise at Roth - Cantech Letter
10 Undervalued Medical Device Stocks to Buy Now - Insider Monkey
BTIG Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Zimmer upgraded to Buy at Roth Capital on Monogram deal (ZBH:NYSE) - Seeking Alpha
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions - AI Insider
Wall Street's Top Analyst Calls: Upgrades and Downgrades for Zimmer Biomet, Southwest, DoorDash, and More - AInvest
What Makes Zimmer Biomet Holdings (ZBH) an Investment Opportunity? - Insider Monkey
Zimmer Biomet Merges with Monogram Technologies - The Globe and Mail
Zimmer Biomet to acquire Monogram for $177m - Yahoo Finance
Zimmer Biomet Acquires Monogram Technologies for $144M in Cash and Earnout - AInvest
Why Zimmer Biomet Holdings Inc. stock attracts strong analyst attentionFree Stock Market Entry & Exit Signals - beatles.ru
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Monogram Technologies Inc. (NASDAQ: MGRM) - GlobeNewswire Inc.
Zimmer Biomet Announces Definitive Agreement To Acquire Monogram - timesuniononline.com
Zimmer Biomet to acquire Monogram Technologies for $177M - The Robot Report
Small Healthcare Stocks Enjoy Big Wins On Deal News - Finimize
Zimmer Biomet to buy Monogram for $177M in cash - MSN
Zimmer Biomet Holdings, Inc. agreed to acquire Monogram Technologies Inc. for $144 million. - MarketScreener
Su Group Holdings Limited shares rise 9.62% intraday due to Zimmer Biomet's acquisition of Monogram Technologies. - AInvest
Zimmer Biomet to acquire Texas orthopedic robotics company - Inside INdiana Business
Zimmer Biomet in $168M buy of ortho robotics maker Monogram - BioWorld MedTech
Zimmer Biomet to Acquire Monogram Technologies for $177M to Offer First Fully Autonomous Surgical Robot - HIT Consultant
Zimmer Biomet Bets Big On Robotic Surgery With $177 Million Deal - Finimize
Zimmer Biomet to acquire robotics company Monogram Technologies - Modern Healthcare
Zimmer Biomet acquisition of Monogram Technologies to expand capacity in robotics devices - The Journal Gazette
Citi maintains Neutral rating on Zimmer Biomet stock amid Monogram acquisition - Investing.com
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):